Effects of the cyclooxygenase inhibitor, piroxicam, in combination with chemotherapy on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer

Molecular Cancer Therapeutics

Volumn 2, Issue 2, 2003, Pages 183-188

  Mohammed, Sulma I ^a   Craig, Bruce A ^b   Mutsaers, Anthony J ^a   Glickman, Nita W ^c   Snyder, Paul W ^a   DeGortari, Amalia E ^a   Schlittler, Deborah L ^a   Coffman, Karen T ^a   Bonney, Patty L ^a   Knapp, Deborah W ^a  

^a PURDUE UNIVERSITY   (United States)

^b PURDUE UNIVERSITY   (United States)

^c PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ENDOTHELIAL CELL GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2; ISOENZYME; LYMPHOKINE; PIROXICAM; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR; SIGNAL PEPTIDE; VASCULOTROPIN; VASCULOTROPIN A;

ANIMAL; ANIMAL DISEASE; APOPTOSIS; ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; CANCER INVASION; CELL DIVISION; COMPARATIVE STUDY; DISEASE MODEL; DOG; DOG DISEASE; DRUG EFFECT; ENZYME IMMUNOASSAY; FEMALE; MALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); TRANSITIONAL CELL CARCINOMA; URINE; VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; CISPLATIN; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DISEASE MODELS, ANIMAL; DOG DISEASES; DOGS; ENDOTHELIAL GROWTH FACTORS; FEMALE; FIBROBLAST GROWTH FACTOR 2; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; ISOENZYMES; LYMPHOKINES; MALE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PIROXICAM; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; URINARY BLADDER NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 17544402702     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Lynch, P. M. COX-2 inhibition in clinical cancer prevention. Oncology, 15 (Suppl. 5): 21-26, 2001. (Pubitemid 33739179)
2. Reddy, B. S., Hirose, Y., Lubet, R., Steele, V., Kelloff, G., Paulson, S., Seibert, K., and Rao, C. V. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res, 60: 293-297, 2000. (Pubitemid 30070754)
3. Soriano, A. F., Helfrich, B., Chan, D. C., Heasley, L. E., Bunn, P. A., Jr., and Chou, T. C. Synergistic effects of new chemopreventive agents and conventional cytotoxic agents against human lung cancer cell lines. Cancer Res, 59: 6178-6184, 1999. (Pubitemid 30035640)
4. Knapp, D. W., Glickman, N. W., Widmer, W. R., DeNicola, D. B., Adams, L. G., Kuczek, T., Bonney, P. L., DeGortari, A. E., Han, C., and Glickman, L. T. Cisplatin versus cisplatin combined with piroxicam in a canine model of human invasive urinary bladder cancer. Cancer Chemother. Pharmacol., 46: 221-226, 2000.
5. Knapp, D. W., Chan, T. C., Kuczek, T., Reagan, W. J., and Park, B. Evaluation of in vitro cytotoxicity of nonsteroidal anti-inflammatory drugs against canine tumor cells. Am. J. Vet. Res., 56: 801-805, 1995.
6. Dempke, W., Rie, C., Grothey, A., and Schmoll, H. J. Cyclooxygenase-2: a novel target for cancer chemotherapy? J. Cancer Res. Clin. Oncol., 127: 411-417, 2001. (Pubitemid 32524357)
7. Mohammed, S. I., Bennett, P. F., Craig, B. A., Glickman, N. W., Mutsaers, A. J., Snyder, P. W., Widmer, W. R., DeGortari, A. E., Bonney, P. L., Knapp, D. W. Effects of the cyclooxygenase inhibitor, piroxicam, on tumor response, apoptosis, and angiogenesis in a canine model of human invasive urinary bladder cancer. Cancer Res, 62: 338-340, 2002.
8. Fosslien, E. Biochemistry of cyclooxygenase (cox)-2 inhibitors and molecular pathology of cox-2 in neoplasia. Crit. Rev. Clin. Lab. Sci., 37: 431-502, 2000. (Pubitemid 32173442)
9. Moore, B. C., Simmons, D. L. Cox-2 inhibition, apoptosis, and chemoprevention by nonsteroidal anti-inflammatory drugs. Curr. Med. Chem., 7: 1131-1144, 2000.
10. Chun, R., Knapp, D. W., Widmer, W. R., DeNicola, D. B., Glickman, N. W., Kuczek, T., deGortari, A., and Han, C. M. Phase II clinical trial of carboplatin in canine transitional cell carcinoma of the urinary bladder. J. Vet. Intern. Med., 11: 279-283, 1997.
11. Khan, K. N., Venturini, C. M., Bunch, R. T., Brassard, J. A., Koki, A. T., Morris, D. L., Trump, B. F., Maziasz, T. J., and Alden, C. L. Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal anti-inflammatory drug-related nephrotoxicity. Toxicol Pathol, 26(5): 612-620, 1998. (Pubitemid 28462712)
12. Weidner, N. Tumor angiogenesis: review of current applications in tumor prognostication. Semin. Diagn. Pathol., 10: 302-313, 1993. (Pubitemid 24038034)
13. Allen, D. K., Waters, D. J., Knapp, D. W., and Kuczek, T. High urine concentrations of basic fibroblast growth factor in dogs with bladder cancer. J. Vet. Intern. Med., 10: 231-234, 1996. (Pubitemid 126701143)
14. Lazarous, D. F., Shou, M., Stiber, J. A., Hodge, E., Thirumurti, V., Goncalves, L., and Unger, E. F. Adenoviral-mediated genes transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis. Cardiovasc. Res., 44: 294-302, 1999. (Pubitemid 29474092)
15. Gu, J. W., Elam, J., Sartin, A., Li, W., Roach, R., and Adair, T. H. Moderate levels of ethanol induce expression of vascular endothelial growth factor and stimulate angiogenesis. Am. J. Physiol. Regul. Integr. Comp. Physiol., 282: R365-R372, 2001.
16. Jingjing, L., Srinivasan, B., Bian, X., Downey, H. F., and Roque, R. S. Vascular endothelial growth factor is increased following coronary artery occlusion in the dog heart. Mol. Cell. Biochem, 214: 23-30, 2000. (Pubitemid 32010323)
17. Landstorm, M., Damber, J. E., and Bergh, A. Prostatic tumor regrowth after initially successful castration therapy may be related to a decreased apoptotic cell death rate. Cancer Res, 54: 4281-4284, 1994.
18. 2 concentrations in naturally-occurring canine cancer. Prostaglandins Leukot. Essent. Fatty Acids, 64: 1-4, 2001.
19. Rohde, D., Brehmer, B., Kapp, T., Valdor, M., and Jakse, G. Induction of drug-resistant bladder carcinoma cells in vitro: impact on polychemotherapy with cisplatin, methotrexate and vinblastine (CMV). Urol. Res., 26: 249-257, 1998. (Pubitemid 28416997)
20. Koukourakis, M. I. Amifostine in clinical oncology: current use and future applications. Anticancer Drugs, 13: 181-209, 2002. (Pubitemid 34492701)
21. Ogilvie, G. K., Straw, R. C., Jameson, V. J., Walters, L. M., Lafferty, M., Powers, B. E., Henkel, S. E., and Withrow, S. J. Prevalence of nephrotoxicosis associated with a four-hour saline solution diuresis protocol for the administration of cisplatin to dogs with naturally developing neoplasms. J. Am. Vet. Med. Assoc., 202: 1845-1848, 1993. (Pubitemid 23196138)
22. Knapp, D. W., Richardson, R. C., Bottoms, G. D., Teclaw, R., and Chan, T. C. Phase I trial of piroxicam in 62 dogs bearing naturally-occurring tumors. Cancer Chemother. Pharmacol., 29: 214-218, 1992.
23. Knapp, D. W., Richardson, R. C., Bonney, P. L., and Hahn, K. Cisplatin therapy in 41 dogs with malignant tumors. J. Vet. Intern. Med., 2: 41-46, 1988.
24. Tsujii M. COX-2 inhibitor and colon cancer. Gan To Kagaku Ryoho, 28: 1799-805, 2001.
25. Henkels, K. M., and Turchi, J. J. Induction of apoptosis in cisplatin-sensitive and -resistant human ovarian cancer cell lines. Cancer Res, 57: 4488-4492, 1997. (Pubitemid 27441050)
26. Godwin, A. K., Meister, A., O'Dwyer, P. J., Huang, C. S., Hamilton, T. C., and Anderson, M. E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA, 89: 3070-3074, 1992.
27. Folkman, J. Angiogenesis research: from laboratory to clinic. Forum (Genova), 9 (Suppl. 3): 59-62, 1999.
28. Folkman, J., Browder, T., and Palmblad, J. Angiogenesis research: guidelines for translation to clinical application. Thromb. Haemostasis, 86: 23-33, 2001. (Pubitemid 32663933)
29. Owen, L. N. World Health Organization TNM classification of tumors in domestic animals. In: S. Withrow and E. MacEwen (eds.), Clinical Veterinary Oncology, pp. 471-473. Philadelphia, PA: J. B. Lippincott Company, 1989.